Suppr超能文献

遗传检测在遗传性心血管疾病中的作用:综述。

Role of Genetic Testing in Inherited Cardiovascular Disease: A Review.

机构信息

Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts.

Department of Cardiology, The Thoraxcenter, Erasmus University Medical Center, Rotterdam, the Netherlands.

出版信息

JAMA Cardiol. 2017 Oct 1;2(10):1153-1160. doi: 10.1001/jamacardio.2017.2352.

Abstract

IMPORTANCE

Genetic testing is a valuable tool for managing inherited cardiovascular disease in patients and families, including hypertrophic, dilated, and arrhythmogenic cardiomyopathies and inherited arrhythmias. By identifying the molecular etiology of disease, genetic testing can improve diagnostic accuracy and refine family management. However, unique features associated with genetic testing affect the interpretation and application of results and differentiate it from traditional laboratory-based diagnostics. Clinicians and patients must have accurate and realistic expectations about the yield of genetic testing and its role in management. Familiarity with the rationale, implications, benefits, and limitations of genetic testing is essential to achieve the best possible outcomes.

OBSERVATIONS

Successfully incorporating genetic testing into clinical practice requires (1) recognizing when inherited cardiovascular disease may be present, (2) identifying appropriate individuals in the family for testing, (3) selecting the appropriate genetic test, (4) understanding the complexities of result interpretation, and (5) effectively communicating the results and implications to the patient and family. Obtaining a detailed family history is critical to identify families who will benefit from genetic testing, determine the best strategy, and interpret results. Instead of focusing on an individual patient, genetic testing requires consideration of the family as a unit. Consolidation of care in centers with a high level of expertise is recommended. Clinicians without expertise in genetic testing will benefit from establishing referral or consultative networks with experienced clinicans in specialized multidisciplinary clinics.

CONCLUSIONS AND RELEVANCE

Genetic testing provides a foundation for transitioning to more precise and individualized management. By distinguishing phenotypic subgroups, identifying disease mechanisms, and focusing family care, gene-based diagnosis can improve management. Successful integration of genetic testing into clinical practice requires understanding of the complexities of testing and effective communication of the implications to patients and families.

摘要

重要性

基因检测是管理遗传性心血管疾病患者和家庭的一种有价值的工具,包括肥厚型、扩张型和致心律失常性心肌病以及遗传性心律失常。通过确定疾病的分子病因,基因检测可以提高诊断准确性并完善家族管理。然而,与基因检测相关的独特特征会影响结果的解释和应用,并将其与传统的基于实验室的诊断区分开来。临床医生和患者必须对基因检测的结果及其在管理中的作用有准确和现实的期望。熟悉基因检测的基本原理、影响、益处和局限性对于实现最佳结果至关重要。

观察结果

成功将基因检测纳入临床实践需要(1)认识到遗传性心血管疾病可能存在的情况,(2)确定家族中适合进行检测的个体,(3)选择适当的基因检测,(4)理解结果解释的复杂性,以及(5)有效地将结果和影响传达给患者和家庭。获取详细的家族史对于确定受益于基因检测的家族、确定最佳策略和解释结果至关重要。基因检测不是针对个体患者,而是需要考虑家庭作为一个整体。建议在具有高水平专业知识的中心整合护理。不具备基因检测专业知识的临床医生将受益于与专门的多学科诊所中具有丰富经验的临床医生建立转诊或咨询网络。

结论和相关性

基因检测为实现更精确和个体化的管理奠定了基础。通过区分表型亚组、确定疾病机制和关注家族护理,基于基因的诊断可以改善管理。成功将基因检测纳入临床实践需要理解检测的复杂性,并将其对患者和家庭的影响有效地传达给他们。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验